Your search returned 2 results.

Results
	1.	Vandetanib versus gefitinib in patients with advanced non-small-cell lung cancer: results from a two-part, double-blind, randomized phase ii study. [electronic resource] by Natale, Ronald B Bodkin, David Govindan, Ramaswamy Sleckman, Bethany G Rizvi, Naiyer A Capó, Adolfo Germonpré, Paul Eberhardt, Wilfried E E Stockman, Paul K Kennedy, Sarah J Ranson, Malcolm Producer: 20090605 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study). [electronic resource] by Gómez, Henry L Neciosup, Silvia Tosello, Célia Mano, Max Bines, José Ismael, Gustavo Santi, Patrícia X Pinczowski, Hélio Nerón, Yeni Fanelli, Marcello Fein, Luis Sampaio, Carlos Lerzo, Guillermo Capó, Adolfo Zarba, Juan J Blajman, César Varela, Mirta S Martínez-Mesa, Jeovany Werutsky, Gustavo Barrios, Carlos H Producer: 20161018 In: Clinical breast cancer vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search